Blog

CM pregnancy UTI

The old FDA pregnancy letter categories (A, B, C, D, X) were officially phased out in 2015 and replaced by the Pregnancy and Lactation Labeling Rule (PLLR), but many clinicians still reference the historical categories because they remain familiar for exams and clinical memory.

Here are the historical categories plus the current practical guidance:

Drug

Old FDA Pregnancy Category

Current Practical Guidance

Nitrofurantoin

B

Generally considered safe in pregnancy except near term; avoid during labor/delivery if possible

Trimethoprim-sulfamethoxazole (Bactrim)

D near term; previously C overall depending on trimester

Avoid especially 1st trimester and near delivery if alternatives available

Ciprofloxacin / fluoroquinolones

C

Generally avoided in pregnancy unless benefits outweigh risks

Nitrofurantoin

Nitrofurantoin

Historical category

  • Category B

Main pregnancy concerns

Usually considered safe for:

  • cystitis
  • asymptomatic bacteriuria

Avoid near term (38–42 weeks), during labor, or in neonates because of:

  • theoretical risk of hemolytic anemia
  • especially in G6PD deficiency

Current OB guidance

ACOG guidance on UTIs in pregnancy

  • Reasonable first-line option in 2nd and 3rd trimesters
  • May still be used in 1st trimester if better alternatives unavailable

TMP-SMX (Bactrim)

Trimethoprim-sulfamethoxazole

Historical category

  • Trimethoprim: Category C
  • Sulfonamides near term: often treated functionally as Category D risk

Main pregnancy concerns

First trimester

Trimethoprim is a folate antagonist:

  • concern for neural tube defects
  • congenital malformations

Near term

Sulfonamides may:

  • displace bilirubin
  • increase theoretical risk of kernicterus in newborns

Current practical recommendation

  • Avoid in first trimester if alternatives exist
  • Avoid near delivery if possible
  • Sometimes still used when culture-directed and necessary

Fluoroquinolones

Examples:

  • Ciprofloxacin
  • Levofloxacin

Historical category

  • Category C

Main pregnancy concerns

Animal studies suggested:

  • cartilage toxicity
  • arthropathy in developing fetus

Human data are less alarming than originally feared, but guidelines still generally avoid routine use in pregnancy.

Current recommendation

Avoid unless:

  • resistant organism
  • severe allergy to safer agents
  • maternal benefit outweighs fetal risk

High-Yield Clinical Summary

Drug

1st Trimester

2nd/3rd Trimester

Near Delivery

Nitrofurantoin

Usually acceptable if needed

Commonly used

Avoid if possible

TMP-SMX

Avoid if possible

Sometimes acceptable

Avoid

Fluoroquinolones

Avoid

Avoid

Avoid

Common Board-Style Pearl

For pregnant women with uncomplicated cystitis:

  • cephalexin is commonly safest/default
  • nitrofurantoin frequently used after 1st trimester
  • avoid fluoroquinolones routinely
  • avoid TMP-SMX early and late pregnancy if alternatives exist